# Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Organization · id `cardio:org-daiichi-sankyo-europe-gmbh-a-daiichi-sankyo-company` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Daiichi+Sankyo+Europe%2C+GmbH%2C+a+Daiichi+Sankyo+Company>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure (`cardio:ct-nct01101009`)
- Sponsors: The Confirmatory Olmesartan Plaque Regression Study (`cardio:ct-nct01132768`)
- Sponsors: Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes (`cardio:ct-nct02618577`)
- Sponsors: Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (`cardio:ct-nct02866175`)
- Sponsors: Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation (`cardio:ct-nct02942576`)
- Sponsors: triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE (`cardio:ct-nct07440381`)

## Provenance

Content hash: 7d173811df8f37353d8d114a5700830339fe9b74803a4612965d8b014db0003e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
